Determinants of Very Severe Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry
Eur. J. Cancer 2021 Oct 06;[EPub Ahead of Print], V Ruste, V Goldschmidt, A Laparra, S Messayke, FX Danlos, P Romano-Martin, S Champiat, AL Voisin, C Baldini, C Massard, S Laghouati, A Marabelle, O Lambotte, JM MichotFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.